grant

Capturing New Drugs That Selectively Modulate PAR2 Signaling Pathways [ 2013 - 2015 ]

Also known as: Designing cleaner antiinflammatory and anticancer drugs with fewer side effects

Research Grant

[Cite as https://purl.org/au-research/grants/nhmrc/1047759]

Researchers: Prof David Fairlie (Principal investigator)

Brief description Infection and tissue damage provoke acute inflammatory responses that sometimes continue unchecked, leading to different kinds of debilitating inflammatory diseases and cancers. We have discovered a new class of drugs that bind to a new target on human cells and block undesirable prolonged inflammatory responses. This project tests a new strategy to produce 'cleaner' drugs that act more selectively with fewer side effects against a new target in the treatment of arthritis and other inflammatory diseases, diet-induced obesity and cancers.

Funding Amount $AUD 469,088.74

Funding Scheme Project Grants

Notes Standard Project Grant

Click to explore relationships graph
Identifiers
Viewed: [[ro.stat.viewed]]
ACN 633 798 857